On May 22, 2024, AGC Biologics and BioConnection, a contract manufacturing organization specializing in aseptic filling of vials and syringes for clinical and commercial production, announced that they have entered into a new strategic partnership. Under the agreement, the companies aim to provide end-to-end biopharmaceutical development and manufacturing capabilities for drug substance and drug product.
